Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colony Stimulating Factors”

336 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 336 results

Testing effectiveness (Phase 2)Study completedNCT02799472
What this trial is testing

Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 39
Early research (Phase 1)Study completedNCT00002009
What this trial is testing

A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Early research (Phase 1)Study completedNCT00002006
What this trial is testing

A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility

Who this might be right for
HIV InfectionsCytopenias
Sandoz
Large-scale testing (Phase 3)Study completedNCT01196715
What this trial is testing

Comparison Study of Standard Care Against Combination of Growth Factors Agents for Low-risk Myelodysplastic Syndromes

Who this might be right for
Myelodysplastic Syndrome
Barts & The London NHS Trust 360
Post-approval studies (Phase 4)UnknownNCT02971306
What this trial is testing

G-CSF Plus NAC In Severe Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
Post Graduate Institute of Medical Education and Research, Chandigarh 60
Testing effectiveness (Phase 2)Study completedNCT01045460
What this trial is testing

Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Post-approval studies (Phase 4)Not Yet RecruitingNCT06047535
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

Who this might be right for
Neuroblastoma
SciClone Pharmaceuticals 62
Not applicableUnknownNCT04497701
What this trial is testing

Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies

Who this might be right for
LymphomaLeukemia
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 139
Early research (Phase 1)Study completedNCT00000899
What this trial is testing

A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Large-scale testing (Phase 3)Study completedNCT00769704
What this trial is testing

Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Who this might be right for
Melanoma
BioVex Limited 437
Early research (Phase 1)Study completedNCT00258687
What this trial is testing

Vaccine Trial for Clear Cell Sarcoma, Pediatric Renal Cell Carcinoma, Alveolar Soft Part Sarcoma and Children With Stage IV Melanoma

Who this might be right for
Sarcoma, Clear CellSarcoma, Alveolar Soft PartRenal Cell Carcinoma+1 more
Dana-Farber Cancer Institute 12
Testing effectiveness (Phase 2)Ended earlyNCT00450008
What this trial is testing

Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 9
Large-scale testing (Phase 3)Study completedNCT02593513
What this trial is testing

Diafert for Embryo Selection and Fertility Improvement (DESTINy)

Who this might be right for
Infertility
Forest Laboratories 108
Large-scale testing (Phase 3)Study completedNCT01825551
What this trial is testing

The Effect of GCSF in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Tehran University of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00488982
What this trial is testing

Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

Who this might be right for
Prostate Cancer
University of California, San Francisco 125
Large-scale testing (Phase 3)UnknownNCT04351152
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
Humanigen, Inc. 520
Testing effectiveness (Phase 2)WithdrawnNCT04909515
What this trial is testing

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.

Who this might be right for
Neuroblastoma
Y-mAbs Therapeutics
Not applicableStudy completedNCT00912418
What this trial is testing

Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma

Who this might be right for
Melanoma
Craig L Slingluff, Jr 14
Post-approval studies (Phase 4)Study completedNCT04009941
What this trial is testing

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerNeutropenia
Peking University 104
Early research (Phase 1)Study completedNCT02156388
What this trial is testing

Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors

Who this might be right for
Chemotherapy-induced NeutropeniaMetastatic Tumors
Jiangsu T-Mab Biopharma Co.,Ltd 31
Load More Results